Healthcare provider profile · identity verified

Irina Pieleanu, MD

Internal Medicine · BELLINGHAM, MA · NPI 1528228459

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	813	79
Trazodone Hcl	Trazodone Hcl	709	67
Eliquis	Apixaban	591	44
Levothyroxine Sodium	Levothyroxine Sodium	525	48
Amlodipine Besylate	Amlodipine Besylate	461	46
Sertraline Hcl	Sertraline Hcl	414	33
Mirtazapine	Mirtazapine	410	51
Quetiapine Fumarate	Quetiapine Fumarate	357	27
Metoprolol Succinate	Metoprolol Succinate	303	31
Furosemide	Furosemide	298	34
Duloxetine Hcl	Duloxetine Hcl	277	16
Gabapentin	Gabapentin	252	34
Tamsulosin Hcl	Tamsulosin Hcl	245	31
Pantoprazole Sodium	Pantoprazole Sodium	239	28
Divalproex Sodium	Divalproex Sodium	224	27
Metoprolol Tartrate	Metoprolol Tartrate	223	25
Donepezil Hcl	Donepezil Hcl	222	18
Escitalopram Oxalate	Escitalopram Oxalate	218	31
Potassium Chloride	Potassium Chloride	199	16
Memantine Hcl	Memantine Hcl	195	11
Risperidone	Risperidone	183	14
Metformin Hcl	Metformin Hcl	174	26
Famotidine	Famotidine	168	25
Carbidopa-Levodopa	Carbidopa/Levodopa	161	12
Omeprazole	Omeprazole	141	21
Lisinopril	Lisinopril	138	29
Losartan Potassium	Losartan Potassium	134	21
Midodrine Hcl	Midodrine Hcl	129	suppressed
Baclofen	Baclofen	121	16
Spironolactone	Spironolactone	113	suppressed
Torsemide	Torsemide	113	11
Citalopram Hbr	Citalopram Hydrobromide	112	13
Januvia	Sitagliptin Phosphate	111	suppressed
Bupropion Xl	Bupropion Hcl	95	suppressed
Buspirone Hcl	Buspirone Hcl	94	17
Clopidogrel	Clopidogrel Bisulfate	94	14
Enoxaparin Sodium	Enoxaparin Sodium	84	suppressed
Pravastatin Sodium	Pravastatin Sodium	81	suppressed
Atenolol	Atenolol	80	suppressed
Levetiracetam	Levetiracetam	78	suppressed
Olanzapine	Olanzapine	75	suppressed
Carvedilol	Carvedilol	73	14
Jardiance	Empagliflozin	73	suppressed
Myrbetriq	Mirabegron	73	suppressed
Bupropion Hcl Sr	Bupropion Hcl	72	suppressed
Ibuprofen	Ibuprofen	69	suppressed
Lorazepam	Lorazepam	65	15
Ranolazine Er	Ranolazine	65	suppressed
Finasteride	Finasteride	64	suppressed
Simvastatin	Simvastatin	63	suppressed
Oxycodone Hcl	Oxycodone Hcl	62	22
Sucralfate	Sucralfate	61	suppressed
Amiodarone Hcl	Amiodarone Hcl	60	suppressed
Clonazepam	Clonazepam	58	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	56	suppressed
Methenamine Hippurate	Methenamine Hippurate	55	suppressed
Tradjenta	Linagliptin	55	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	14
Hydrochlorothiazide	Hydrochlorothiazide	52	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	48	suppressed
Aripiprazole	Aripiprazole	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	47	suppressed
Tramadol Hcl	Tramadol Hcl	47	16
Ezetimibe	Ezetimibe	46	suppressed
Galantamine Er	Galantamine Hbr	46	suppressed
Allopurinol	Allopurinol	45	suppressed
Methimazole	Methimazole	45	suppressed
Creon	Lipase/Protease/Amylase	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	43	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	42	suppressed
Folic Acid	Folic Acid	40	suppressed
Permethrin	Permethrin	40	28
Cefpodoxime Proxetil	Cefpodoxime Proxetil	39	24
Isosorbide Dinitrate	Isosorbide Dinitrate	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Metformin Hcl Er	Metformin Hcl	38	suppressed
Nuplazid	Pimavanserin Tartrate	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Cephalexin	Cephalexin	36	18
Entacapone	Entacapone	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lithium Carbonate	Lithium Carbonate	36	suppressed
Metolazone	Metolazone	36	suppressed
Mirabegron Er	Mirabegron	36	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	36	suppressed
Rivastigmine	Rivastigmine	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	11
Naproxen	Naproxen	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Primidone	Primidone	30	suppressed
Ssd	Silver Sulfadiazine	30	13
Albuterol Sulfate Hfa	Albuterol Sulfate	29	17
Ondansetron Hcl	Ondansetron Hcl	29	14
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	11
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	14
Hydralazine Hcl	Hydralazine Hcl	25	suppressed
Nyamyc	Nystatin	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	13
Entresto	Sacubitril/Valsartan	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Santyl	Collagenase Clostridium Hist.	22	suppressed
Vraylar	Cariprazine Hcl	22	suppressed
Alogliptin	Alogliptin Benzoate	21	suppressed
Lacosamide	Lacosamide	21	suppressed
Levofloxacin	Levofloxacin	21	12
Insulin Lispro	Insulin Lispro	20	suppressed
Novolog	Insulin Aspart	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	19	suppressed
Lactulose	Lactulose	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	suppressed
Glipizide	Glipizide	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Humalog	Insulin Lispro	17	suppressed
Nystatin	Nystatin	17	suppressed
Ramelteon	Ramelteon	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Benztropine Mesylate	Benztropine Mesylate	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Digoxin	Digoxin	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Prednisone	Prednisone	15	12
Rivastigmine	Rivastigmine Tartrate	15	suppressed
Topiramate	Topiramate	15	suppressed
Amantadine	Amantadine Hcl	14	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Clozapine	Clozapine	14	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	13	13
Azithromycin	Azithromycin	12	suppressed
Indapamide	Indapamide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Steglatro	Ertugliflozin Pidolate	12	suppressed
Admelog	Insulin Lispro	11	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clozapine Odt	Clozapine	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error